CD-38: Emerging Therapeutic Target in Immunology and Oncology

agregó una foto Health

2025-09-28 12:19:30

The CD-38 Market is evolving rapidly as researchers and pharmaceutical companies explore therapies targeting CD-38, a multifunctional protein involved in immune regulation, cancer progression, and cellular metabolism. With growing relevance in immunology and oncology, understanding CD-38’s biological role, therapeutic potential, and market dynamics is essential for stakeholders and...

0 Commentarios 0 Acciones 312 Views 0 Vista previa